Log In
Print
BCIQ
Print
Print this Print this
 

Anti-CD40L Fab (CD40L, CDP7657)

  Manage Alerts
Collapse Summary General Information
Company Biogen Idec Inc.
DescriptionFab antibody targeting CD40 ligand (CD40L)
Molecular Target CD40 ligand (CD40LG) (CD40L) (CD154)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation

Partner

UCB Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today